Celgene Enters Into Service and License Arrangement for GNS Healthcare’s Causal Machine Learning Platform to Accelerate Value-Based and Precision Medicine Development

CAMBRIDGE, Mass. – November 29, 2016 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to massive and diverse data streams to better match drugs and other health interventions to individual patients, today announced that Celgene Corporation has entered into a service and license arrangement for the rights to […]

GNS Healthcare Announces Investment by Horizon Healthcare Services, Inc. to Expand Strategic Partnership Focused on Precision Medicine in Population Health

CAMBRIDGE, Mass. – May 23, 2016 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new target intervention pathways, today announced an investment by Horizon Healthcare Services, Inc. (New Jersey). The investment supports a strategic collaboration between the companies and […]

GNS Healthcare Study with Pfizer Reveals Discovery of Novel Clinical Risk Factors Driving Progression to Type 2 Diabetes and Prediabetes

Published by the Journal of Diabetes Science and Technology, Discoveries Result From Computer Models Created From EHR Data and Causal Machine Learning Technology CAMBRIDGE, Mass. – Feb. 29, 2016 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new intervention […]

Boston Business Journal: GNS Healthcare raises $10M for big data

GNS Healthcare Inc. has raised a $10 million Series B funding round led by existing investor Cambia Health Solutions, based in Portland Oregon. New investors, California’s Heritage Provider Network and Mitsui & Co also joined the round. The announcement follows the Cambridge company’s expansion to a second office in Austin, Texas, and a plan to […]